Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W0NU
|
|||
| Former ID |
DNCL001978
|
|||
| Drug Name |
NIC5-15
|
|||
| Synonyms |
D-Pinitol; Pinitol; 10284-63-6; 3-O-Methyl-D-chiro-inositol; (+)-Pinitol; D-(+)-Pinitol; Inzitol; Methylinositol; Sennitol; 1-D-4-O-METHYL-MYO-INOSITOL; Pinit; D-ononitol; Ononitol; 1D-4-O-Methyl-myo-inositol; 1D-3-O-methyl-chiro-inositol; D-chiro-Inositol, 3-O-methyl-; 4-O-Methyl-myo-inositol; UNII-TF9HZN9T0M; UNII-A998ME07KR; 5D-5-O-Methyl-chiro-inositol; 6090-97-7; (1r,2s,4s,5s)-6-methoxycyclohexane-1,2,3,4,5-pentol; TF9HZN9T0M; 484-68-4; Matezit; Sennit; CHEMBL493737; A998ME07KR; CHEBI:28548; DSCFFEYYQKSRSV-KLJZZCKASA-N; NSC 43336
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1] | |
| Company |
Humanetics Minneapolis, MN
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H14O6
|
|||
| Canonical SMILES |
COC1C(C(C(C(C1O)O)O)O)O
|
|||
| InChI |
1S/C7H14O6/c1-13-7-5(11)3(9)2(8)4(10)6(7)12/h2-12H,1H3/t2?,3-,4-,5-,6+,7?/m0/s1
|
|||
| InChIKey |
DSCFFEYYQKSRSV-FEPQRWDDSA-N
|
|||
| CAS Number |
CAS 484-68-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
6581, 8588, 3155012, 3722559, 8144322, 11533103, 12015429, 15171584, 15195390, 16143257, 24867648, 32964008, 34883167, 42613911, 46238788, 48394212, 57350488, 57390994, 57392457, 74348299, 77606223, 91695992, 92297531, 93620589, 103069827, 103078090, 103612712, 104118995, 113454442, 117557283, 118046756, 119525293, 124365766, 127778904, 132570187, 135120758, 135653842, 136991802, 137147437, 139694673, 139694700, 143492567, 144106862, 144115877, 144233669, 152057788, 152164787, 152238566, 162224562, 162859147
|
|||
| ChEBI ID |
CHEBI:28548
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01928420) A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease. U.S. National Institutes of Health. | |||
| REF 2 | Combating neurodegenerative disease with chemical probes and model systems. Nat Chem Biol. 2014 Nov;10(11):911-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.